Annual Operating Expenses
$247.14 M
-$24.60 M-9.05%
31 December 2023
Summary:
Lyell Immunopharma annual total operating expenses is currently $247.14 million, with the most recent change of -$24.60 million (-9.05%) on 31 December 2023. During the last 3 years, it has risen by +$27.45 million (+12.49%). LYEL annual operating expenses is now -9.05% below its all-time high of $271.74 million, reached on 31 December 2022.LYEL Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$50.54 M
-$1.00 M-1.94%
30 September 2024
Summary:
Lyell Immunopharma quarterly total operating expenses is currently $50.54 million, with the most recent change of -$1.00 million (-1.94%) on 30 September 2024. Over the past year, it has dropped by -$8.53 million (-14.43%). LYEL quarterly operating expenses is now -52.18% below its all-time high of $105.68 million, reached on 30 June 2020.LYEL Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.1% | -14.4% |
| 3 y3 years | +12.5% | -2.6% |
| 5 y5 years | - | - |
LYEL Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -9.1% | +12.5% | -30.8% | +0.4% |
| 5 y | 5 years | -9.1% | +140.5% | -52.2% | +47.5% |
| alltime | all time | -9.1% | +140.5% | -52.2% | +47.5% |
Lyell Immunopharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $50.54 M(-1.9%) |
| June 2024 | - | $51.54 M(-7.3%) |
| Mar 2024 | - | $55.58 M(-6.6%) |
| Dec 2023 | $247.14 M(-9.1%) | $59.52 M(+0.8%) |
| Sept 2023 | - | $59.06 M(-10.4%) |
| June 2023 | - | $65.93 M(+5.3%) |
| Mar 2023 | - | $62.62 M(-0.9%) |
| Dec 2022 | $271.74 M | $63.17 M(-4.9%) |
| Sept 2022 | - | $66.44 M(-9.0%) |
| June 2022 | - | $73.00 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $69.13 M(+37.3%) |
| Dec 2021 | $225.43 M(+2.6%) | $50.36 M(-3.0%) |
| Sept 2021 | - | $51.92 M(-20.5%) |
| June 2021 | - | $65.33 M(+13.0%) |
| Mar 2021 | - | $57.81 M(+38.2%) |
| Dec 2020 | $219.69 M(+113.8%) | - |
| Dec 2020 | - | $41.84 M(+10.3%) |
| Sept 2020 | - | $37.91 M(-64.1%) |
| June 2020 | - | $105.68 M(+208.5%) |
| Mar 2020 | - | $34.26 M |
| Dec 2019 | $102.75 M | - |
FAQ
- What is Lyell Immunopharma annual total operating expenses?
- What is the all time high annual operating expenses for Lyell Immunopharma?
- What is Lyell Immunopharma annual operating expenses year-on-year change?
- What is Lyell Immunopharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly operating expenses year-on-year change?
What is Lyell Immunopharma annual total operating expenses?
The current annual operating expenses of LYEL is $247.14 M
What is the all time high annual operating expenses for Lyell Immunopharma?
Lyell Immunopharma all-time high annual total operating expenses is $271.74 M
What is Lyell Immunopharma annual operating expenses year-on-year change?
Over the past year, LYEL annual total operating expenses has changed by -$24.60 M (-9.05%)
What is Lyell Immunopharma quarterly total operating expenses?
The current quarterly operating expenses of LYEL is $50.54 M
What is the all time high quarterly operating expenses for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly total operating expenses is $105.68 M
What is Lyell Immunopharma quarterly operating expenses year-on-year change?
Over the past year, LYEL quarterly total operating expenses has changed by -$8.53 M (-14.43%)